Matches in SemOpenAlex for { <https://semopenalex.org/work/W2359554423> ?p ?o ?g. }
- W2359554423 endingPage "201" @default.
- W2359554423 startingPage "201" @default.
- W2359554423 abstract "Tuberculosis (TB) is the main infectious disease causing 1.8 million deaths worldwide every year and represents a principal cause of mortality resulting from a bacterial infection. The emergence of multidrug-resistant strains and lack of effective anti-TB drugs are threatening the future control of TB. The present multidrug regimen against TB needs daily administration for at least 6 months, and patients often fail to follow this complex regimen for such a long interval, thus leading to patient non-compliance and treatment related side effects. To avoid daily dosing, application of nanotechnology is a promising solution by virtue of sustained drug release. Nanotechnology-based rational targeting may improve therapeutic success by limiting adverse drug effects and requiring less frequent administration regimens, ultimately resulting in higher patient compliance, and thus attain higher adherence levels. Today, the pipeline of potential new treatments consists of several compounds in clinical trials or preclinical development with promising activities against sensitive and resistant Mycobacterium tuberculosis strains. Encapsulation of existing anti-TB drugs into nano-delivery systems and introduction of new drugs in combination treatment for all forms of tuberculosis have resulted in novel treatments with more effectiveness and reduced side effects.Keywords: Tuberculosis, Nanotechnology, Anti-tuberculosis drugs, Nano carriers, Rifampicin" @default.
- W2359554423 created "2016-06-24" @default.
- W2359554423 creator A5004972725 @default.
- W2359554423 creator A5009677306 @default.
- W2359554423 creator A5030188071 @default.
- W2359554423 creator A5078387343 @default.
- W2359554423 creator A5079030672 @default.
- W2359554423 creator A5084187441 @default.
- W2359554423 date "2016-05-11" @default.
- W2359554423 modified "2023-10-17" @default.
- W2359554423 title "Nanoformulations and Clinical Trial Candidates as Probably Effective and Safe Therapy for Tuberculosis" @default.
- W2359554423 cites W1481716780 @default.
- W2359554423 cites W1529101966 @default.
- W2359554423 cites W1585765690 @default.
- W2359554423 cites W1585891721 @default.
- W2359554423 cites W1786188424 @default.
- W2359554423 cites W1867075303 @default.
- W2359554423 cites W1964291085 @default.
- W2359554423 cites W1969586092 @default.
- W2359554423 cites W1986106712 @default.
- W2359554423 cites W1988583295 @default.
- W2359554423 cites W1991713951 @default.
- W2359554423 cites W1992071749 @default.
- W2359554423 cites W2001770989 @default.
- W2359554423 cites W2005427343 @default.
- W2359554423 cites W2016195561 @default.
- W2359554423 cites W2016812928 @default.
- W2359554423 cites W2021068830 @default.
- W2359554423 cites W2022258204 @default.
- W2359554423 cites W2026537351 @default.
- W2359554423 cites W2032468019 @default.
- W2359554423 cites W2048874605 @default.
- W2359554423 cites W2050919716 @default.
- W2359554423 cites W2054273338 @default.
- W2359554423 cites W2063766636 @default.
- W2359554423 cites W2067629397 @default.
- W2359554423 cites W2073502830 @default.
- W2359554423 cites W2077623418 @default.
- W2359554423 cites W2095256039 @default.
- W2359554423 cites W2098146193 @default.
- W2359554423 cites W2098562002 @default.
- W2359554423 cites W2098793988 @default.
- W2359554423 cites W2109725458 @default.
- W2359554423 cites W2112487751 @default.
- W2359554423 cites W2115434346 @default.
- W2359554423 cites W2119052084 @default.
- W2359554423 cites W2124011355 @default.
- W2359554423 cites W2129055298 @default.
- W2359554423 cites W2129314857 @default.
- W2359554423 cites W2132559847 @default.
- W2359554423 cites W2132941113 @default.
- W2359554423 cites W2134476763 @default.
- W2359554423 cites W2139451383 @default.
- W2359554423 cites W2142133270 @default.
- W2359554423 cites W2145085703 @default.
- W2359554423 cites W2147467826 @default.
- W2359554423 cites W2148686571 @default.
- W2359554423 cites W2155742575 @default.
- W2359554423 cites W2155750714 @default.
- W2359554423 cites W2157183580 @default.
- W2359554423 cites W2158616316 @default.
- W2359554423 cites W2164282552 @default.
- W2359554423 cites W2167372213 @default.
- W2359554423 cites W2181828741 @default.
- W2359554423 cites W2182027132 @default.
- W2359554423 cites W22564445 @default.
- W2359554423 cites W2340931467 @default.
- W2359554423 cites W2396176685 @default.
- W2359554423 cites W349827422 @default.
- W2359554423 cites W57368190 @default.
- W2359554423 cites W89757394 @default.
- W2359554423 doi "https://doi.org/10.4314/tjpr.v15i1.28" @default.
- W2359554423 hasPublicationYear "2016" @default.
- W2359554423 type Work @default.
- W2359554423 sameAs 2359554423 @default.
- W2359554423 citedByCount "9" @default.
- W2359554423 countsByYear W23595544232018 @default.
- W2359554423 countsByYear W23595544232019 @default.
- W2359554423 countsByYear W23595544232020 @default.
- W2359554423 countsByYear W23595544232022 @default.
- W2359554423 countsByYear W23595544232023 @default.
- W2359554423 crossrefType "journal-article" @default.
- W2359554423 hasAuthorship W2359554423A5004972725 @default.
- W2359554423 hasAuthorship W2359554423A5009677306 @default.
- W2359554423 hasAuthorship W2359554423A5030188071 @default.
- W2359554423 hasAuthorship W2359554423A5078387343 @default.
- W2359554423 hasAuthorship W2359554423A5079030672 @default.
- W2359554423 hasAuthorship W2359554423A5084187441 @default.
- W2359554423 hasBestOaLocation W23595544231 @default.
- W2359554423 hasConcept C142724271 @default.
- W2359554423 hasConcept C177713679 @default.
- W2359554423 hasConcept C2781069245 @default.
- W2359554423 hasConcept C71924100 @default.
- W2359554423 hasConceptScore W2359554423C142724271 @default.
- W2359554423 hasConceptScore W2359554423C177713679 @default.
- W2359554423 hasConceptScore W2359554423C2781069245 @default.
- W2359554423 hasConceptScore W2359554423C71924100 @default.
- W2359554423 hasIssue "1" @default.